These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15231627)

  • 21. Measuring patient safety: the need for prospective detection of adverse events.
    Bates DW
    Stud Health Technol Inform; 2009; 148():3. PubMed ID: 19957414
    [No Abstract]   [Full Text] [Related]  

  • 22. Automatic generation of MedDRA terms groupings using an ontology.
    Declerck G; Bousquet C; Jaulent MC
    Stud Health Technol Inform; 2012; 180():73-7. PubMed ID: 22874155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data mining to generate adverse drug events detection rules.
    Chazard E; Ficheur G; Bernonville S; Luyckx M; Beuscart R
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):823-30. PubMed ID: 21859604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards better reporting of adverse drug reactions.
    Prescrire Int; 2012 May; 21(127):128-9. PubMed ID: 22827004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collaborative improves monitoring of vaccine safety.
    Gearon CJ
    AHIP Cover; 2007; 48(5):16-8, 20, 22-4. PubMed ID: 17941571
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse drug reactions.
    Shuttleworth A
    Nurs Times; 2006 Jul 25-31; 102(30):58. PubMed ID: 16903313
    [No Abstract]   [Full Text] [Related]  

  • 27. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug-induced fatal adverse effects in the United States from 1999 to 2004].
    He M; Guo QL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1060-5. PubMed ID: 19060378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
    Härmark L; van Hunsel F; Hak E; van Grootheest K
    Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serious adverse drug reactions in older adults notified to pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):465-70. PubMed ID: 23241256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four initiatives proposed to improve safety reporting in clinical trials.
    J Support Oncol; 2004; 2(5):431-2. PubMed ID: 15524071
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database.
    Kane-Gill SL; Van Den Bos J; Handler SM
    Ann Pharmacother; 2010 Jun; 44(6):983-93. PubMed ID: 20442350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of adverse drug events detection: data aggregation and data mining.
    Chazard E; Ficheur G; Merlin B; Genin M; Preda C; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():75-84. PubMed ID: 19745237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program.
    Singh G
    J Rheumatol; 2001 May; 28(5):1174-9. PubMed ID: 11361209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How well do patient reports reflect adverse drug reactions reported by rheumatologists? Agreement of physician- and patient-reported adverse events in patients with rheumatoid arthritis observed in the German biologics register.
    Gäwert L; Hierse F; Zink A; Strangfeld A
    Rheumatology (Oxford); 2011 Jan; 50(1):152-60. PubMed ID: 20871128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
    Ludwig WD
    Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
    [No Abstract]   [Full Text] [Related]  

  • 39. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methods for identification of adverse events of frequent drugs in regulatives use. Differences between questioning or spontaneous informing of the incidence].
    Wink K; Feige A
    MMW Fortschr Med; 2011 Oct; 153 Suppl 3():71-4. PubMed ID: 22184799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.